Clinical Trials
4 trialsNCT04756037 2026-05-13
SERENE
Sumitomo Pharma Switzerland GmbH
Phase 3 Completed
NCT05726786 2025-12-09
INCyst
Centre Hospitalier Universitaire Vaudois
Phase 3 Recruiting
NCT05862272 2025-08-06
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
Phase 3 Recruiting
NCT00865488 2009-12-23
Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery
OMRIX Biopharmaceuticals
Phase 3 Suspended